126 related articles for article (PubMed ID: 24533727)
1. Acute cellular rejection the first year after heart transplantation and its impact on survival: a single-centre retrospective study at Skåne University Hospital in Lund 1988-2010.
Söderlund C; Öhman J; Nilsson J; Higgins T; Kornhall B; Johansson L; Rådegran G
Transpl Int; 2014 May; 27(5):482-92. PubMed ID: 24533727
[TBL] [Abstract][Full Text] [Related]
2. Acute cellular rejection later than one year after heart transplantation: A single-center retrospective study at Skåne University Hospital in Lund 1988-2010.
Söderlund C; Rådegran G
Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28480572
[TBL] [Abstract][Full Text] [Related]
3. [Pathology of heart transplantation.(Morphological study of 1246 endomyocardial biopsies from 167 transplanted hearts). Causes of early, intermediate, and late deaths].
Agozzino L; Thomopoulos K; Esposito S; Agozzino M; De Vivo F; Maiello C; Cotrufo M
Pathologica; 1999 Apr; 91(2):89-100. PubMed ID: 10484868
[TBL] [Abstract][Full Text] [Related]
4. Limited utility of endomyocardial biopsy in the first year after heart transplantation.
Hamour IM; Burke MM; Bell AD; Panicker MG; Banerjee R; Banner NR
Transplantation; 2008 Apr; 85(7):969-74. PubMed ID: 18408576
[TBL] [Abstract][Full Text] [Related]
5. Late rejection occurred in recipients who experienced acute cellular rejection within the first year after heart transplantation.
Imamura T; Kinugawa K; Nitta D; Fujino T; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Yao A; Kyo S; Ono M
Int Heart J; 2015; 56(2):174-9. PubMed ID: 25740393
[TBL] [Abstract][Full Text] [Related]
6. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.
Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M
Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425
[TBL] [Abstract][Full Text] [Related]
7. Endomyocardial Biopsy and Prevalence of Acute Cellular Rejection in Heart Transplantation.
Sinphurmsukskul S; Ariyachaipanich A; Siwamogsatham S; Thammanatsakul K; Puwanant S; Benjacholamas V; Ongcharit P
Transplant Proc; 2021; 53(1):318-323. PubMed ID: 33041079
[TBL] [Abstract][Full Text] [Related]
8. How many endomyocardial biopsies are necessary in the first year after heart transplantation?
Sisson S; Jazzar A; Mischke L; Cooper DK; Zuhdi N
Transpl Int; 1996; 9(3):243-7. PubMed ID: 8723194
[TBL] [Abstract][Full Text] [Related]
9. Surveillance Endomyocardial Biopsy in the Modern Era Produces Low Diagnostic Yield for Cardiac Allograft Rejection.
Shah KB; Flattery MP; Smallfield MC; Merinar G; Tang DG; Sheldon EH; Thacker LR; Kasirajan V; Cooke RH; Hess ML
Transplantation; 2015 Aug; 99(8):e75-80. PubMed ID: 25706277
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of the switch to generic mycophenolate mofetil and tacrolimus in heart transplant patients.
Söderlund C; Rådegran G
Clin Transplant; 2015 Jul; 29(7):619-28. PubMed ID: 25981927
[TBL] [Abstract][Full Text] [Related]
11. Timing of the first endomyocardial biopsy in heart transplantation after induction immunosuppressive therapy--experience from Canadian Heart Transplant Centre.
Málek F; Kaan A; Straatman L; Cheung A; Gnaszewski A
Cas Lek Cesk; 2005; 144(8):507-9; discussion 509. PubMed ID: 16173602
[TBL] [Abstract][Full Text] [Related]
12. Endomyocardial biopsy in heart transplantation: schedule or event?
Chi NH; Chou NK; Tsao CI; Huang SC; Wu IH; Yu HY; Chen YS; Wang SS
Transplant Proc; 2012 May; 44(4):894-6. PubMed ID: 22564577
[TBL] [Abstract][Full Text] [Related]
13. A single-center retrospective clinicopathologic study of endomyocardial biopsies after heart transplant at Baskent University Hospital in Ankara, 1993-2014.
Terzi A; Sezgin A; Tunca Z; Deniz E; Ayva EŞ; Haberal Reyhan N; Müderrisoğlu H; Özdemir BH
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():346-51. PubMed ID: 25894188
[TBL] [Abstract][Full Text] [Related]
14. The influence of donor-related factors on the frequency of acute cellular rejection by the recipient in the first year following heart transplantation.
Sobieszczańska-Małek M; Zieliński T; Korewicki J
Ann Transplant; 2007; 12(4):38-43. PubMed ID: 18344937
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of the Quilty effect in endomyocardial biopsy of patients after heart transplantation - from cellular rejection to antibody-mediated rejection?
Szymanska S; Grajkowska W; Sobieszczanska-Malek M; Zielinski T; Pyzlak M; Pronicki M
Pol J Pathol; 2016; 67(3):216-220. PubMed ID: 28155969
[TBL] [Abstract][Full Text] [Related]
16. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted?
Winters GL; Loh E; Schoen FJ
Circulation; 1995 Apr; 91(7):1975-80. PubMed ID: 7895355
[TBL] [Abstract][Full Text] [Related]
17. Quantitative short-tandem repeat analysis of recipient-derived cells as an additional tool for diagnosing cardiac allograft rejection.
Pichler M; Beckendorf J; Winter E; Kleinert R; Kniepeiss D; Hoefler G
Transplantation; 2010 Mar; 89(6):749-55. PubMed ID: 19997059
[TBL] [Abstract][Full Text] [Related]
18. Apollon/RNF41 myocardial messenger RNA diagnoses cardiac allograft apoptosis in rejection.
Aharinejad S; Andrukhova O; Gmeiner M; Thomas A; Krenn K; Zuckermann A; Grimm M
Transplantation; 2010 Jan; 89(2):245-52. PubMed ID: 20098290
[TBL] [Abstract][Full Text] [Related]
19. Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection.
Fedrigo M; Feltrin G; Poli F; Frigo AC; Benazzi E; Gambino A; Tona F; Caforio AL; Castellani C; Toscano G; Gerosa G; Thiene G; Angelini A
J Heart Lung Transplant; 2013 Apr; 32(4):404-9. PubMed ID: 23498161
[TBL] [Abstract][Full Text] [Related]
20. Are surveillance endomyocardial biopsies necessary during OKT3 induction therapy?
Daoud AJ; Bhat G; Schroeder TJ
Transplantation; 1997 Jul; 64(2):368-70. PubMed ID: 9256204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
